KRAS and lung cancer: In this case, GEM models provide an ideal system in which to study the contribution of individual mutations to each step of tumor initiation and progression without the complications of mutagen-induced genome hypermutation as is common in KRAS-mutated human lung cancer cells (Chalmers et al., 2017).